Journal of Cardiovascular Disease Research
TEG GUIDED PRE-PROCEDURE COAGULOPATHY SCREEN IN CIRRHOTICS
Dr. Shivadatta Padhi, Dr. Vandana Tyagi, Dr. Sudhir Maharshi, Dr. Gaurav Gupta, Dr. Sandeep Nijhawan
JCDR. 2024: 1439-1449
Abstract
Background and Aims Hemostasis in cirrhotics exist in rebalance, defects in prohemostatic drivers are compensated by commensurate changes in antihemostatic drivers. Conventional coagulation tests (CCTs) in cirrhotics assess only procoagulant factors therefore poor predictors of bleeding risk. CCTs are routinely used before invasive procedures and attempts are made to correct these abnormalities before invasive procedures such practices are not evidence-based, and may even be harmful. Thromboelastography (TEG) hence is promising in evaluating the coagulation status of cirrhotics prior to procedures. TEG-guided transfusion can avoid unnecessary blood product transfusions. Methods The prospective study included 133 cirrhotic patients undergoing central line placement, Conventional coagulation tests (CCTs), and Thromboelastography (TEG) were done in all patients and they were observed for postprocedural bleeding.
» PDF